Background Inhaled short acting beta2 adrenergic agonists and ipratropium bromide are
both used in the treatment of acute exacerbations of chronic obstructive pulmonary disease …

Objective. To evaluate the efficacy of β2-agonists in bronchiolitis. Design. Critical review and
meta-analysis of randomized controlled trials of inhaled β2-agonists. Results. Three …

Background The benefits and risks of antibiotics for acute bronchitis remain unclear despite
it being one of the most common illnesses seen in primary care. Objectives To assess the …

Background Patients with acute asthma treated in the emergency department are frequently
treated with intermittent inhaled beta‐agonists delivered by nebulisation. The use of …

Background In acute asthma inhaled beta₂‐agonists are often administered by nebuliser to
relieve bronchospasm, but some have argued that metered‐dose inhalers with a holding …

Background Inhaled short‐acting beta‐2 agonists are the major class of bronchodilators
used for relief of symptoms in asthma. There has been concern that excessive uncontrolled …

PREVIEW The optimal therapy for acute bronchitis depends on the causative pathogen and
the presence or absence of underlying lung disease. Because there is no fast, reliable way …

BACKGROUND: The use of β2 agonist as an intervention for acute lung injury (ALI) and
ARDS patients is controversial, so we performed a systematic review and meta-analysis of …

Background Inhaled bronchodilators form the mainstay of treatment for acute exacerbations
of COPD. Two types of agent are used routinely, either singly or in combination …

Background Chronic obstructive pulmonary disease (COPD) is a respiratory disease that
causes progressive symptoms of breathlessness, cough and mucus build‐up. It is the fourth …